Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 111,288Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3BRISTOL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEUCRAVACITINIB

US Patent Number : 11021475

Drug Substance Claim :

Drug Product Claim :

Application Number : 214958

Patent Use Code : U-3434

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-07

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEUCRAVACITINIB

US Patent Number : RE47929

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214958

Patent Use Code : U-3434

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-07

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEUCRAVACITINIB

US Patent Number : 10000480

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214958

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-07

blank